Which is the best glomerular filtration marker: Creatinine, cystatin C or both?
European Journal of Clinical Investigation · 2024-10 · 54 (10)
DOI: 10.1111/eci.14278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024-07. Verfasst von Thomas Stehlé und 1 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Service de Néphrologie et Transplantation, Fédération Hospitalo-Universi…. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, Creatinine, Biomarkers. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The glomerular filtration rate (GFR) is estimated by the serum or plasma concentration of creatinine and/or cystatin C using equations that include demographic data. The equations worldwide most widely used are those of the Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) consortium and updated in 2021 to remove the Afro‐American racial correction factor. In 2021 and then in 2023, the European Kidney Function Consortium also developed equations based on creatinine and cystatin C, usable across the full age spectrum, and constructed by including the Q value (i.e. the median creatinine or cystatin C in healthy men and women, which is customizable for specific populations).
Methods
The aim of this narrative review is to examine the strengths and weaknesses of each biomarker.
Results
Both biomarkers have non‐GFR determinants, namely muscle mass, protein intake and tubular secretion for creatinine; dysthyroidism and systemic corticosteroids for cystatin C, as well as other more debated determinants (diabetes, obesity, proteinuria, inflammatory syndrome). These non‐GFR determinants are the reason why no equation based on a single endogenous biomarker has an accuracy within 30% greater than 90% over the entire age spectrum (in at least one patient in 10, estimated GFR is at least 30% higher or at least 30% lower than the measured GFR).
Conclusion
Equations combining the two biomarkers provide a better estimate of GFR, particularly in the subgroup of patients whose estimates based on each of the biomarkers are highly discordant. These patients must also be identified as being at increased risk of morbidity, particularly cardiovascular, and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Service de Néphrologie et Transplantation, Fédération Hospitalo-Universitaire «Innovative therapy for immune disorders», Créteil, France.
- Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Univ. Paris Est Créteil, Créteil, France.
- Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium.
- Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France.
ORCID-Profile: Thomas Stehlé
Zitieren
APA
Stehlé, T., & Delanaye, P. (2024). Which is the best glomerular filtration marker: Creatinine, cystatin C or both?. European Journal of Clinical Investigation, 54(10). https://doi.org/10.1111/eci.14278
Vancouver
Stehlé T, Delanaye P. Which is the best glomerular filtration marker: Creatinine, cystatin C or both?. European Journal of Clinical Investigation. 2024;54(10). doi:10.1111/eci.14278
BibTeX
@article{Stehl2024,
author = {Stehlé, Thomas and Delanaye, Pierre},
title = {Which is the best glomerular filtration marker: Creatinine, cystatin C or both?},
journal = {European Journal of Clinical Investigation},
year = {2024},
volume = {54},
number = {10},
doi = {10.1111/eci.14278}
}
EUVIMED